Actxa Participates in AI Asia Expo Thailand 2023
Singapore, 14 February 2023 –Actxa Pte Ltd (“Actxa”) is proud to present our award-winning Blood Glucose Evaluation & Monitoring (BGEM™)...
top of page
- Aug 8, 2022
Actxa and Joint Chinese Limited Launch Actxa’s Non-Invasive Blood Glucose Monitoring Tech
The MOU was signed by Mr Joel Chin, CEO of Actxa (left), and Mr James Yan, CEO of Joint Chinese Limited (right). Photo by: Actxa Pte Ltd...
- Jul 20, 2022
Actxa Partners With the Singapore Heart Foundation In Promoting Heart Health in Singapore
For immediate release Singapore, 15 July 2022 – This year, Actxa Pte. Ltd (“Actxa”) has partnered with the Singapore Heart Foundation...
- Jun 10, 2022
Actxa Receives Award for AI – Healthcare Technology in the SBR Technology Excellence Awards 2022
Singapore, 13 May 2022 – Actxa Pte.Ltd (“Actxa”), a homegrown AI-driven preventive health solutions company, has been awarded the SBR...
- Sep 27, 2021
Actxa & KK Women’s and Children’s Hospital Research Non-invasive Blood Glucose Monitor on Wearables
For immediate release Singapore, 27 September 2021 – Actxa and KK Women’s and Children’s Hospital (KKH) are carrying out a clinical study...
- Jul 22, 2021
Actxa Announces Launch of Actxa Wellness Pte Ltd and Leadership Transition
Bringing Corporate Wellness Closer to Doorsteps of Corporations For immediate release Singapore, 21 July 2021 – Celebrating its sixth...
bottom of page